Literature DB >> 23336043

Animal models of serotonergic psychedelics.

James B Hanks1, Javier González-Maeso.   

Abstract

The serotonin 5-HT(2A) receptor is the major target of psychedelic drugs such as lysergic acid diethylamide (LSD), mescaline, and psilocybin. Serotonergic psychedelics induce profound effects on cognition, emotion, and sensory processing that often seem uniquely human. This raises questions about the validity of animal models of psychedelic drug action. Nonetheless, recent findings suggest behavioral abnormalities elicited by psychedelics in rodents that predict such effects in humans. Here we review the behavioral effects induced by psychedelic drugs in rodent models, discuss the translational potential of these findings, and define areas where further research is needed to better understand the molecular mechanisms and neuronal circuits underlying their neuropsychological effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23336043      PMCID: PMC3547517          DOI: 10.1021/cn300138m

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  146 in total

Review 1.  Serotonergic receptor subtypes and hallucinogen-induced stimulus control.

Authors:  J C Winter; D J Fiorella; D M Timineri; R A Filipink; S E Helsley; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  1999-10       Impact factor: 3.533

2.  1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.

Authors:  Thomas H McLean; Jason C Parrish; Michael R Braden; Danuta Marona-Lewicka; Alejandra Gallardo-Godoy; David E Nichols
Journal:  J Med Chem       Date:  2006-09-21       Impact factor: 7.446

3.  Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.

Authors:  N A Darmani
Journal:  Pharmacol Biochem Behav       Date:  2001-02       Impact factor: 3.533

4.  DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation.

Authors:  Lena Wischhof; Helena E A Aho; Michael Koch
Journal:  Pharmacol Biochem Behav       Date:  2012-03-25       Impact factor: 3.533

5.  Effects of psilocybin on time perception and temporal control of behaviour in humans.

Authors:  Marc Wittmann; Olivia Carter; Felix Hasler; B Rael Cahn; Ulrike Grimberg; Philipp Spring; Daniel Hell; Hans Flohr; Franz X Vollenweider
Journal:  J Psychopharmacol       Date:  2006-05-19       Impact factor: 4.153

6.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

Review 7.  Serotonin research: contributions to understanding psychoses.

Authors:  Mark A Geyer; Franz X Vollenweider
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

8.  Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice.

Authors:  Suzanne C Wood; Stephan G Anagnostaras
Journal:  Psychopharmacology (Berl)       Date:  2008-05-15       Impact factor: 4.530

9.  Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.

Authors:  M Ukai; T Kameyama
Journal:  Brain Res       Date:  1985-07-01       Impact factor: 3.252

10.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

Authors:  S J CORNE; R W PICKERING; B T WARNER
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  45 in total

1.  Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.

Authors:  José L Moreno; Patricia Miranda-Azpiazu; Aintzane García-Bea; Jason Younkin; Meng Cui; Alexey Kozlenkov; Ariel Ben-Ezra; Georgios Voloudakis; Amanda K Fakira; Lia Baki; Yongchao Ge; Anastasios Georgakopoulos; José A Morón; Graeme Milligan; Juan F López-Giménez; Nikolaos K Robakis; Diomedes E Logothetis; J Javier Meana; Javier González-Maeso
Journal:  Sci Signal       Date:  2016-01-12       Impact factor: 8.192

2.  Controlled substances and innovation of biomedicine: a preclinical perspective.

Authors:  Adam Michael Stewart; Allan V Kalueff
Journal:  Nat Rev Neurosci       Date:  2013-10-23       Impact factor: 34.870

Review 3.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

4.  HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.

Authors:  Mario de la Fuente Revenga; Daisuke Ibi; Justin M Saunders; Travis Cuddy; Maryum K Ijaz; Rudy Toneatti; Mitsumasa Kurita; Terrell Holloway; Li Shen; Jeremy Seto; Mikhail G Dozmorov; Javier González-Maeso
Journal:  Neuroscience       Date:  2018-07-17       Impact factor: 3.590

5.  Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.

Authors:  Mario de la Fuente Revenga; Urjita H Shah; Nima Nassehi; Alaina M Jaster; Prithvi Hemanth; Salvador Sierra; Malgorzata Dukat; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2021-01-05       Impact factor: 4.418

6.  What's old is new.

Authors:  Anne M Andrews; Lynette C Daws
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

Review 7.  Current approaches for the discovery of drugs that deter substance and drug abuse.

Authors:  Adam Yasgar; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2014-09-24       Impact factor: 6.098

Review 8.  Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

Authors:  Nikhil Neelkantan; Alina Mikhaylova; Adam Michael Stewart; Raymond Arnold; Visar Gjeloshi; Divya Kondaveeti; Manoj K Poudel; Allan V Kalueff
Journal:  ACS Chem Neurosci       Date:  2013-08-06       Impact factor: 4.418

9.  Interclass GPCR heteromerization affects localization and trafficking.

Authors:  Rudy Toneatti; Jong M Shin; Urjita H Shah; Carl R Mayer; Justin M Saunders; Miguel Fribourg; Paul T Arsenovic; William G Janssen; Stuart C Sealfon; Juan F López-Giménez; Deanna L Benson; Daniel E Conway; Javier González-Maeso
Journal:  Sci Signal       Date:  2020-10-20       Impact factor: 8.192

10.  HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice.

Authors:  Terrell Holloway; Jose L Moreno; Javier González-Maeso
Journal:  J Vis Exp       Date:  2016-07-09       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.